Clinical Trial Update: Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

View source ↗

Summary

This ClinicalTrials.gov entry describes a study by A2 Biotherapeutics evaluating HLA LOH analysis and apheresis for CAR-T cell manufacturing across multiple sol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma
• Mesothelioma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma
• Triple-negative Breast Cancer

Drugs mentioned

• Investigational CAR-T cell therapy

Snippet

Sponsor: A2 Biotherapeutics Inc. | Conditions: Solid Tumor, Adult, Colorectal Cancer | Status: RECRUITING